NCT04796467 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients Status UNKNOWN Phase PHASE2/PHASE3
NCT04794777 Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer Status RECRUITING Phase PHASE3
NCT04792138 Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis. Status UNKNOWN Phase N/A
NCT04787744 Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer Status RECRUITING Phase PHASE2/PHASE3
NCT04783636 To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers Status UNKNOWN Phase PHASE1
NCT04781374 Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer Status WITHDRAWN Phase PHASE2
NCT04775602 Experimental Study to Evaluate the Impact of 18 Fluoro-PSMA (18F-PSMA) PET / CT in the Management of Patients with Prostate Cancer. Status COMPLETED Phase PHASE2
NCT04773821 Performance of Prostate MRI and Following Biopsy to Detect Prostate Cancer Recurrence After Focal Therapy Status UNKNOWN Phase NA
NCT04769817 ProsTIC Registry of Men Treated With PSMA Theranostics Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04766190 DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer Status RECRUITING Phase NA
NCT04763824 KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice Status COMPLETED Phase NA
NCT04751929 Abemaciclib With or Without Atezolizumab for mCRPC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04751435 Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients Status RECRUITING Phase NA
NCT04751201 Meditation and Cancer, Pilot Feasibility Study (MAEva Pilot Study) Status COMPLETED Phase NA
NCT04748042 Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04746638 Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m RM26 Status COMPLETED Phase PHASE1
NCT04745871 Diagnostic Performance of PSMA PET/CT for Pre-operative Lymph Node Assessment in Intermediate and High-risk Non-metastasic Prostate Cancer (PREOP-PSMA ). Status RECRUITING Phase NA